Silver
Research stageAlso known as Ag - Silver, Silver and/or silver compound.
Recent clinical, regulatory, research and industry developments relating to this drug.
Nanoparticles in Medicine: Current Status in Cancer Treatment.
A review of current advancements for wound healing: Biomaterial applications and medical devices.
Green nanotechnology: a review on green synthesis of silver nanoparticles - an ecofriendly approach.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Scientific reports2
- ACS applied materials & interfaces1
- ACS nano1
- International journal of molecular sciences1
- International journal of nanomedicine1
- Journal of biomedical materials research. Part B, Applied biomaterials1
- Abo-Elmagd RA1
- Agaj A1
- Ahmad AN1
- Ahmad S1
- Alamzeb M1
- Ali J1
- Ali MA1
- Ali S1
- Centre for Bioengineering & Nanomedicine (Dunedin)1
- General Hospital Pula1
- Genetic Engineering & Research Institute1
- Government Girls Degree College1
- ICFO-Institut de Ciencies Fotoniques1
- Institute of Chemical Sciences1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across the same disease area as Silver in the shared literature.
Studied across the same disease area as Silver in the shared literature.
Studied across the same disease area as Silver in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature